CIK 0001705843
- Non-accelerated filer
- Smaller reporting company
Cibus, Inc.
Sign in to watch- Ticker
- CBUS
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271967997
- Phone
- +1 858-450-0008
- Business address
- 6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Former names
- Calyxt, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Frey Travis Chief Technology Officer | Returned to the company · Stock Option (Right-to-Buy) | −250,000 | 0 | ||
| 2023-03-01 | Frey Travis Chief Technology Officer | Grant or award · Stock Option (Right-to-Buy) | +250,000 | 250,000 | ||
| 2023-03-01 | Carr Michael A. President and CEO | Returned to the company · Stock Option (Right-to-Buy) | −200,000 | 0 | ||
| 2023-03-01 | Carr Michael A. President and CEO | Grant or award · Stock Option (Right-to-Buy) | +200,000 | 200,000 | ||
| 2023-03-01 | Carr Michael A. President and CEO | Returned to the company · Stock Option (Right-to-Buy) | −490,000 | 0 | ||
| 2023-03-01 | Carr Michael A. President and CEO | Grant or award · Stock Option (Right-to-Buy) | +490,000 | 490,000 | ||
| 2023-03-01 | Dumont Philippe Director | Returned to the company · Stock Option (Right-to-Buy) | −5,000 | 0 | ||
| 2023-03-01 | Dumont Philippe Director | Grant or award · Stock Option (Right-to-Buy) | +5,000 | 5,000 | ||
| 2023-03-01 | Dumont Philippe Director | Returned to the company · Stock Option (Right-to-Buy) | −10,291 | 0 | ||
| 2023-03-01 | Dumont Philippe Director | Grant or award · Stock Option (Right-to-Buy) | +10,291 | 10,291 | ||
| 2023-03-01 | Dumont Philippe Director | Returned to the company · Stock Option (Right-to-Buy) | −32,700 | 0 | ||
| 2023-03-01 | Dumont Philippe Director | Grant or award · Stock Option (Right-to-Buy) | +32,700 | 32,700 | ||
| 2023-03-01 | Jonathan Fassberg Director | Returned to the company · Stock Option (Right-to-Buy) | −5,000 | 0 | ||
| 2023-03-01 | Jonathan Fassberg Director | Grant or award · Stock Option (Right-to-Buy) | +5,000 | 5,000 | ||
| 2023-03-01 | Jonathan Fassberg Director | Returned to the company · Stock Option (Right-to-Buy) | −10,291 | 0 | ||
| 2023-03-01 | Jonathan Fassberg Director | Grant or award · Stock Option (Right-to-Buy) | +10,291 | 10,291 | ||
| 2023-03-01 | Jonathan Fassberg Director | Returned to the company · Stock Option (Right-to-Buy) | −32,700 | 0 | ||
| 2023-03-01 | Jonathan Fassberg Director | Grant or award · Stock Option (Right-to-Buy) | +32,700 | 32,700 | ||
| 2023-03-01 | Kozicz-Stankiewicz Anna Ewa Director | Returned to the company · Stock Option (Right-to-Buy) | −5,000 | 0 | ||
| 2023-03-01 | Kozicz-Stankiewicz Anna Ewa Director | Grant or award · Stock Option (Right-to-Buy) | +5,000 | 5,000 |
Page 13 of 19 · 365 trades